Boston Scientific (NYSE: BSX) today announced a catheter development and commercialization deal with Siemens Healthineers.

Boston Scientific anticipates that assisting in commercialising Siemens Healthineers’ 4D ICE catheter will pay dividends for ...

Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ...

After selling RDN developer SoniVie to Boston Scientific for $600 million, Ray Cohen discusses competing devices from ...

A Boston Scientific official announced the enrollment of the first patients in the OPTIMIZE randomized controlled clinical trial.

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Oct 25 (Reuters) - Boston Scientific's BSX.N quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could ...

Boston Scientific has put forward pivotal clinical data from a head-to-head trial showing its pulsed field ablation approach for treating an irregular heartbeat can operate on par with traditional ...

Marlborough, Mass.-based Boston Scientific has launched Endura Weight Loss Solutions, a new category name for its minimally invasive endobariatric procedures such as endoscopic sleeve gastroplasty and ...

(Reuters) -Boston Scientific raised its annual profit forecast on Wednesday, after the medical device maker beat third-quarter profit estimates on strong demand for its heart devices. The company, ...

Oct 25 (Reuters) - Boston Scientific's (BSX.N), opens new tab quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical ...